Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats
Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an en...
Gespeichert in:
Veröffentlicht in: | Brain research 1994-09, Vol.658 (1), p.192-198 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 198 |
---|---|
container_issue | 1 |
container_start_page | 192 |
container_title | Brain research |
container_volume | 658 |
creator | Wang, Qiong Theard, Mary A. Pelligrino, Dale A. Baughman, Verna L. Hoffman, William E. Albrecht, Ronald F. Cwik, Michael Paulson, Olaf B. Lassen, Niels A. |
description | Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an endogenous anticonvulsant or proconvulsant substance? and (2) is the cerebral blood flow (CBF) increase accompanying bicuculline (BC)-induced seizures mediated by NO? The experiments were performed in 300–400-g Wistar rats anesthetized with 0.6% halothane and 70% N
2O/30% O
2. CBF was measured using the intracarotid
133Xe clearance method or laser-Doppler flowmetry. EEG activity was recorded. Chronic treatment (4 days) with nitro-
L-arginine (
L-NA), a potent NO synthase (NOS) inhibitor (400 mg/kg total), suppressed brain NOS by > 97% and prolonged seizure duration from 6±1 (saline-treated controls) to 12 ± 2 min. In the
L-NA-treated group, the CBF increase was sustained as long as seizure activity remained, indicating that CBF was still tightly coupled to seizure activity. Interestingly, the supposed inactive enantiomer of
L-NA,
D-NA, also showed an inhibition of brain NOS activity, ranging from 87 to 100%. The duration of seizures in this group (average 8 ± 2 min) corresponded directly to the magnitude of reduction in NOS activity (
r = 0.83,
P < 0.05). Specifically, the
D-NA results indicated that NOS inhibition had to exceed 95% before any effect on seizure duration could be seen. Additional results demonstrated that only a total dose of 400 mg/kg of
L-NA, given chronically was capable of prolonging the BC-induced CBF increase. With acute doses of 5 and 30 mg/kg
L-NA, the time course of CBF changes after BC administration was not different from the control. These findings suggest that endogenous NO acts as an anticonvulsant perhaps via a negative feedback mechanism at the NMDA receptor. NO, however, does not appear to couple neuronal activation to increased CBF in this model. |
doi_str_mv | 10.1016/S0006-8993(09)90026-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16572800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899309900269</els_id><sourcerecordid>16572800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-53d219660649bf194a8614d59a6973efd82316203ae7dfef55752ae1c55a2a6e3</originalsourceid><addsrcrecordid>eNqFkcFuFDEMhiMEKsvCI1TKAaH2MJBkJpnNCaEKaKWqPQDnyJN4SlA2WZKZQnkX3pVMd7VXTrHl33b8_YSccvaWM67efWGMqWajdXvG9LlmTKhGPyErvulFo0THnpLVUfKcvCjlR03bVrMTctLLlsler8jfGz9lb2n67R3Ss5vbc-oLhUgxunSHMc1LNnmb4v0cSg3pME80pokC3aLzMKVM00in70h9tBmhLAG1mHHIEOgQUnJ0DOkXBWvTdgfxwcc7Ong72zkEH7Hx0c0WHS3o_8wZyzIgw1RekmcjhIKvDu-afPv08evFZXN9-_nq4sN1YzvBpka2TnCtFFOdHkauO9go3jmpQem-xdFtRMuVYC1g70YcpeylAORWShCgsF2TN_u5u5x-zlgms_XFYggQsRIwXMlebCq9NZF7oc2plIyj2WW_hfxgODOLLebRFrMwN0ybR1uMrn2nhwXzUKkduw4-1PrrQx2KhTBmiNaXo6xeqesBVfZ-L8MK495jNsV6jBWdz2gn45L_z0f-AVirq54</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16572800</pqid></control><display><type>article</type><title>Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Wang, Qiong ; Theard, Mary A. ; Pelligrino, Dale A. ; Baughman, Verna L. ; Hoffman, William E. ; Albrecht, Ronald F. ; Cwik, Michael ; Paulson, Olaf B. ; Lassen, Niels A.</creator><creatorcontrib>Wang, Qiong ; Theard, Mary A. ; Pelligrino, Dale A. ; Baughman, Verna L. ; Hoffman, William E. ; Albrecht, Ronald F. ; Cwik, Michael ; Paulson, Olaf B. ; Lassen, Niels A.</creatorcontrib><description>Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an endogenous anticonvulsant or proconvulsant substance? and (2) is the cerebral blood flow (CBF) increase accompanying bicuculline (BC)-induced seizures mediated by NO? The experiments were performed in 300–400-g Wistar rats anesthetized with 0.6% halothane and 70% N
2O/30% O
2. CBF was measured using the intracarotid
133Xe clearance method or laser-Doppler flowmetry. EEG activity was recorded. Chronic treatment (4 days) with nitro-
L-arginine (
L-NA), a potent NO synthase (NOS) inhibitor (400 mg/kg total), suppressed brain NOS by > 97% and prolonged seizure duration from 6±1 (saline-treated controls) to 12 ± 2 min. In the
L-NA-treated group, the CBF increase was sustained as long as seizure activity remained, indicating that CBF was still tightly coupled to seizure activity. Interestingly, the supposed inactive enantiomer of
L-NA,
D-NA, also showed an inhibition of brain NOS activity, ranging from 87 to 100%. The duration of seizures in this group (average 8 ± 2 min) corresponded directly to the magnitude of reduction in NOS activity (
r = 0.83,
P < 0.05). Specifically, the
D-NA results indicated that NOS inhibition had to exceed 95% before any effect on seizure duration could be seen. Additional results demonstrated that only a total dose of 400 mg/kg of
L-NA, given chronically was capable of prolonging the BC-induced CBF increase. With acute doses of 5 and 30 mg/kg
L-NA, the time course of CBF changes after BC administration was not different from the control. These findings suggest that endogenous NO acts as an anticonvulsant perhaps via a negative feedback mechanism at the NMDA receptor. NO, however, does not appear to couple neuronal activation to increased CBF in this model.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(09)90026-9</identifier><identifier>PMID: 7530579</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Amino Acid Oxidoreductases - antagonists & inhibitors ; Animals ; Anticonvulsants - metabolism ; Arginine - analogs & derivatives ; Arginine - pharmacology ; Bicuculline ; Biological and medical sciences ; Cerebral blood flow ; Cerebrovascular Circulation - drug effects ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Male ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurology ; Nitric oxide (NO) ; Nitric Oxide - physiology ; Nitric Oxide Synthase ; Nitroarginine ; NMDA receptor ; Rats ; Rats, Wistar ; Seizure ; Seizures - chemically induced ; Seizures - physiopathology ; Stereoisomerism</subject><ispartof>Brain research, 1994-09, Vol.658 (1), p.192-198</ispartof><rights>1994 Elsevier Science B.V. All rights reserved</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-53d219660649bf194a8614d59a6973efd82316203ae7dfef55752ae1c55a2a6e3</citedby><cites>FETCH-LOGICAL-c420t-53d219660649bf194a8614d59a6973efd82316203ae7dfef55752ae1c55a2a6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006899309900269$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4209162$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7530579$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Qiong</creatorcontrib><creatorcontrib>Theard, Mary A.</creatorcontrib><creatorcontrib>Pelligrino, Dale A.</creatorcontrib><creatorcontrib>Baughman, Verna L.</creatorcontrib><creatorcontrib>Hoffman, William E.</creatorcontrib><creatorcontrib>Albrecht, Ronald F.</creatorcontrib><creatorcontrib>Cwik, Michael</creatorcontrib><creatorcontrib>Paulson, Olaf B.</creatorcontrib><creatorcontrib>Lassen, Niels A.</creatorcontrib><title>Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an endogenous anticonvulsant or proconvulsant substance? and (2) is the cerebral blood flow (CBF) increase accompanying bicuculline (BC)-induced seizures mediated by NO? The experiments were performed in 300–400-g Wistar rats anesthetized with 0.6% halothane and 70% N
2O/30% O
2. CBF was measured using the intracarotid
133Xe clearance method or laser-Doppler flowmetry. EEG activity was recorded. Chronic treatment (4 days) with nitro-
L-arginine (
L-NA), a potent NO synthase (NOS) inhibitor (400 mg/kg total), suppressed brain NOS by > 97% and prolonged seizure duration from 6±1 (saline-treated controls) to 12 ± 2 min. In the
L-NA-treated group, the CBF increase was sustained as long as seizure activity remained, indicating that CBF was still tightly coupled to seizure activity. Interestingly, the supposed inactive enantiomer of
L-NA,
D-NA, also showed an inhibition of brain NOS activity, ranging from 87 to 100%. The duration of seizures in this group (average 8 ± 2 min) corresponded directly to the magnitude of reduction in NOS activity (
r = 0.83,
P < 0.05). Specifically, the
D-NA results indicated that NOS inhibition had to exceed 95% before any effect on seizure duration could be seen. Additional results demonstrated that only a total dose of 400 mg/kg of
L-NA, given chronically was capable of prolonging the BC-induced CBF increase. With acute doses of 5 and 30 mg/kg
L-NA, the time course of CBF changes after BC administration was not different from the control. These findings suggest that endogenous NO acts as an anticonvulsant perhaps via a negative feedback mechanism at the NMDA receptor. NO, however, does not appear to couple neuronal activation to increased CBF in this model.</description><subject>Amino Acid Oxidoreductases - antagonists & inhibitors</subject><subject>Animals</subject><subject>Anticonvulsants - metabolism</subject><subject>Arginine - analogs & derivatives</subject><subject>Arginine - pharmacology</subject><subject>Bicuculline</subject><subject>Biological and medical sciences</subject><subject>Cerebral blood flow</subject><subject>Cerebrovascular Circulation - drug effects</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Nitric oxide (NO)</subject><subject>Nitric Oxide - physiology</subject><subject>Nitric Oxide Synthase</subject><subject>Nitroarginine</subject><subject>NMDA receptor</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Seizure</subject><subject>Seizures - chemically induced</subject><subject>Seizures - physiopathology</subject><subject>Stereoisomerism</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFuFDEMhiMEKsvCI1TKAaH2MJBkJpnNCaEKaKWqPQDnyJN4SlA2WZKZQnkX3pVMd7VXTrHl33b8_YSccvaWM67efWGMqWajdXvG9LlmTKhGPyErvulFo0THnpLVUfKcvCjlR03bVrMTctLLlsler8jfGz9lb2n67R3Ss5vbc-oLhUgxunSHMc1LNnmb4v0cSg3pME80pokC3aLzMKVM00in70h9tBmhLAG1mHHIEOgQUnJ0DOkXBWvTdgfxwcc7Ong72zkEH7Hx0c0WHS3o_8wZyzIgw1RekmcjhIKvDu-afPv08evFZXN9-_nq4sN1YzvBpka2TnCtFFOdHkauO9go3jmpQem-xdFtRMuVYC1g70YcpeylAORWShCgsF2TN_u5u5x-zlgms_XFYggQsRIwXMlebCq9NZF7oc2plIyj2WW_hfxgODOLLebRFrMwN0ybR1uMrn2nhwXzUKkduw4-1PrrQx2KhTBmiNaXo6xeqesBVfZ-L8MK495jNsV6jBWdz2gn45L_z0f-AVirq54</recordid><startdate>19940926</startdate><enddate>19940926</enddate><creator>Wang, Qiong</creator><creator>Theard, Mary A.</creator><creator>Pelligrino, Dale A.</creator><creator>Baughman, Verna L.</creator><creator>Hoffman, William E.</creator><creator>Albrecht, Ronald F.</creator><creator>Cwik, Michael</creator><creator>Paulson, Olaf B.</creator><creator>Lassen, Niels A.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>19940926</creationdate><title>Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats</title><author>Wang, Qiong ; Theard, Mary A. ; Pelligrino, Dale A. ; Baughman, Verna L. ; Hoffman, William E. ; Albrecht, Ronald F. ; Cwik, Michael ; Paulson, Olaf B. ; Lassen, Niels A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-53d219660649bf194a8614d59a6973efd82316203ae7dfef55752ae1c55a2a6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Amino Acid Oxidoreductases - antagonists & inhibitors</topic><topic>Animals</topic><topic>Anticonvulsants - metabolism</topic><topic>Arginine - analogs & derivatives</topic><topic>Arginine - pharmacology</topic><topic>Bicuculline</topic><topic>Biological and medical sciences</topic><topic>Cerebral blood flow</topic><topic>Cerebrovascular Circulation - drug effects</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Nitric oxide (NO)</topic><topic>Nitric Oxide - physiology</topic><topic>Nitric Oxide Synthase</topic><topic>Nitroarginine</topic><topic>NMDA receptor</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Seizure</topic><topic>Seizures - chemically induced</topic><topic>Seizures - physiopathology</topic><topic>Stereoisomerism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Qiong</creatorcontrib><creatorcontrib>Theard, Mary A.</creatorcontrib><creatorcontrib>Pelligrino, Dale A.</creatorcontrib><creatorcontrib>Baughman, Verna L.</creatorcontrib><creatorcontrib>Hoffman, William E.</creatorcontrib><creatorcontrib>Albrecht, Ronald F.</creatorcontrib><creatorcontrib>Cwik, Michael</creatorcontrib><creatorcontrib>Paulson, Olaf B.</creatorcontrib><creatorcontrib>Lassen, Niels A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Qiong</au><au>Theard, Mary A.</au><au>Pelligrino, Dale A.</au><au>Baughman, Verna L.</au><au>Hoffman, William E.</au><au>Albrecht, Ronald F.</au><au>Cwik, Michael</au><au>Paulson, Olaf B.</au><au>Lassen, Niels A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1994-09-26</date><risdate>1994</risdate><volume>658</volume><issue>1</issue><spage>192</spage><epage>198</epage><pages>192-198</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an endogenous anticonvulsant or proconvulsant substance? and (2) is the cerebral blood flow (CBF) increase accompanying bicuculline (BC)-induced seizures mediated by NO? The experiments were performed in 300–400-g Wistar rats anesthetized with 0.6% halothane and 70% N
2O/30% O
2. CBF was measured using the intracarotid
133Xe clearance method or laser-Doppler flowmetry. EEG activity was recorded. Chronic treatment (4 days) with nitro-
L-arginine (
L-NA), a potent NO synthase (NOS) inhibitor (400 mg/kg total), suppressed brain NOS by > 97% and prolonged seizure duration from 6±1 (saline-treated controls) to 12 ± 2 min. In the
L-NA-treated group, the CBF increase was sustained as long as seizure activity remained, indicating that CBF was still tightly coupled to seizure activity. Interestingly, the supposed inactive enantiomer of
L-NA,
D-NA, also showed an inhibition of brain NOS activity, ranging from 87 to 100%. The duration of seizures in this group (average 8 ± 2 min) corresponded directly to the magnitude of reduction in NOS activity (
r = 0.83,
P < 0.05). Specifically, the
D-NA results indicated that NOS inhibition had to exceed 95% before any effect on seizure duration could be seen. Additional results demonstrated that only a total dose of 400 mg/kg of
L-NA, given chronically was capable of prolonging the BC-induced CBF increase. With acute doses of 5 and 30 mg/kg
L-NA, the time course of CBF changes after BC administration was not different from the control. These findings suggest that endogenous NO acts as an anticonvulsant perhaps via a negative feedback mechanism at the NMDA receptor. NO, however, does not appear to couple neuronal activation to increased CBF in this model.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>7530579</pmid><doi>10.1016/S0006-8993(09)90026-9</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-8993 |
ispartof | Brain research, 1994-09, Vol.658 (1), p.192-198 |
issn | 0006-8993 1872-6240 |
language | eng |
recordid | cdi_proquest_miscellaneous_16572800 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Amino Acid Oxidoreductases - antagonists & inhibitors Animals Anticonvulsants - metabolism Arginine - analogs & derivatives Arginine - pharmacology Bicuculline Biological and medical sciences Cerebral blood flow Cerebrovascular Circulation - drug effects Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Male Medical sciences Nervous system (semeiology, syndromes) Neurology Nitric oxide (NO) Nitric Oxide - physiology Nitric Oxide Synthase Nitroarginine NMDA receptor Rats Rats, Wistar Seizure Seizures - chemically induced Seizures - physiopathology Stereoisomerism |
title | Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T16%3A35%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nitric%20oxide%20(NO)%20is%20an%20endogenous%20anticonvulsant%20but%20not%20a%20mediator%20of%20the%20increase%20in%20cerebral%20blood%20flow%20accompanying%20bicuculline-induced%20seizures%20in%20rats&rft.jtitle=Brain%20research&rft.au=Wang,%20Qiong&rft.date=1994-09-26&rft.volume=658&rft.issue=1&rft.spage=192&rft.epage=198&rft.pages=192-198&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(09)90026-9&rft_dat=%3Cproquest_cross%3E16572800%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16572800&rft_id=info:pmid/7530579&rft_els_id=S0006899309900269&rfr_iscdi=true |